23rd week of 2011 patent applcation highlights part 41 |
Patent application number | Title | Published |
20110135695 | ORAL DOSAGE FORM FOR CONTROLLED DRUG RELEASE - An oral dosage form comprising,
| 2011-06-09 |
20110135696 | MULTIPOTENT NEURAL CELLS - The inventions disclosed herein are based on the identification of novel cell populations derived from human embryonic stem cells and other pluripotent cells. The inventive cell populations may be used for cell therapies for the treatment of various neurological diseases and as substrates in pharmacological assays. | 2011-06-09 |
20110135697 | EDIBLE HOLOGRAPHIC SILK PRODUCTS - The present invention relates to edible silk holographic elements and methods for making the same. Edible silk holographic elements are used to label pharmaceuticals and foods, or may be formulated to deliver pharmaceuticals. | 2011-06-09 |
20110135698 | MULTILAYERED BLOOD PRODUCT - A blood product ( | 2011-06-09 |
20110135699 | PARTICLES OF COLLAGEN MATERIAL AND PROCESS FOR THE PREPARATION - In order to provide a product that is suitable as fat substitute in foods, which can be produced simply and inexpensively and is deemed safe from the nutritional physiology viewpoint and with which the typical texture of fat-containing foods can be simulated as favourably as possible, particles of collagen material are proposed which are substantially insoluble and swellable in water, wherein in swollen state the particles have an average diameter of less than approximately 150 μm. A process for the production of this product is additionally proposed. | 2011-06-09 |
20110135700 | IN SITU BULKING COMPOSITION - The present invention relates to a hydrated, biocompatible tissue-augmentation compound and methodology for its implantation into mammalian tissue. The tissue-augmentation compound is comprised of: living tissue, optionally body derived fluids, and at least one NCO-terminated hydrophilic urethane prepolymer derived from an organic polyisocyanate, and oxyethylene-containing diols or polyols in which essentially all of hydroxyl groups are capped with polyisocyanate. | 2011-06-09 |
20110135701 | Functional Cellulosic Moldings - The invention relates to cellulosic moldings having very finely distributed zinc pigments after the dry-wet extrusion method. Cellulosic moldings formed in accordance with the inventive methods, compared to unmodified cellulose fibers, have a high degree of whiteness combined with greatly increased UV light absorption and a wash-resistant bactericidal effect, while at the same time having unrestricted textile processability. The cellulosic functional moldings produced according to the invention are particularly suited for use in textiles for clothing, technical textiles, recreation, medicine, and cosmetics. | 2011-06-09 |
20110135702 | SPORICIDAL COMPOSITION FOR CLOSTRIDIUM DIFFICILE SPORES - A cleaning medium or formulation that contains a sporicidal composition is described. The composition includes about 0.1-20% weight/weight of a germinant agent, about 0.01-75% w/w of an antimicrobial agent, in terms of dry or wet total weight, and which is admixed with water to generate a solution with a pH of 3.5-9.5. The composition can help trigger the germination of spores, in particular | 2011-06-09 |
20110135703 | Antimicrobial Coating for Surgical Implants and Method of Use - A method of treating a surgical incision uses a material coated in an antimicrobial material. The material may be a synthetic mesh, an allograft, or a xenograft. The antimicrobial material is either tryclosan or lysostaphin. The coating of the material is performed either by adsorption or by covalent bonding. | 2011-06-09 |
20110135704 | Infection Control for Surgical and Trauma Patients - Apparatus and methods for disrupting the colonization of | 2011-06-09 |
20110135705 | METHODS AND COMPOSITIONS FOR TISSUE AUGMENTATION - Methods and compositions for use in tissue volume replacement are provided. The present invention comprises compositions comprising a combination of materials, comprising preferably a solid polymer particle phase and a gel phase, and also comprises single phase compositions. More particularly, preferred embodiments comprise a solid polymer particle phase made of materials comprising Gore-Tex (micronized e-PTFE), PDS II (polydioxanone, a monofilament), NUROLON (a long chain aliphatic polymer Nylon 6 or Nylon 6,6) ETHILON (a long chain aliphatic polymer Nylon 6 and Nylon 6,6), PROLENE (Polypropylene, isotactic crystalline stereoisomer of polypropylene, a synthetic linear polyolefin.), VICRYL (copolymer made from 90% glycolide and 10% L-lactide), silk, MONACRYL (poly ε-caprolactone.), polylactide, polyglycolide, poly lactide-co-glycolide, and BIOPOL (polyhydroxyvalerate), MEDPOR (biocompatible (micronized) polyethylene), BIOGLASS (bioactive glass particulate), NOVABONE and NOVABONE-CM, and the gel phase comprises polyvinylpyrrolidone (PVP). Preferred single phase compositions comprise PVP. Methods of the present invention comprising injection of such compositions for tissue augmentation. | 2011-06-09 |
20110135706 | NERVE TREATMENT DEVICES AND METHODS - Devices and methods for treating defects in peripheral nerves are provided. The devices can include acellular arterial tissue matrices that facilitate regrowth of nerve tissue across a gap or defect in a peripheral nerve. | 2011-06-09 |
20110135707 | POLYHYDROXYALKANOATES FOR IN VIVO APPLICATIONS - Polyhydroxyalkanoates (PHAs) from which pyrogen has been removed are provided for use in numerous biomedical applications. PHAs which have been chemically modified to enhance physical and/or chemical properties, for targeting or to modify biodegradability or clearance by the reticuloendothelial system (RES), are described. Methods for depyrogenating PHA polymers prepared by bacterial fermentation processes are also provided, wherein pyrogens are removed from the polymers without adversely impacting the polymers' inherent chemical structures and physical properties. PHAs with advantageous processing characteristics, including low melting points and/or solubility in non-toxic solvents, are also described. PHAs are provided which are suitable for use in in vivo applications such as in tissue coatings, stents, sutures, tubing, bone and other prostheses, bone or tissue cements, tissue regeneration devices, wound dressings, drug delivery, and for diagnostic and prophylactic uses. Properties which are selected for include degradability, elasticity, inclusion of functional groups or derivatized groups, which can in turn be used to attach targeting agents, and bioadhesion. | 2011-06-09 |
20110135708 | DIETARY SUPPLEMENT - LIQUID FILLED GUM - A new chewing gum comprising a gum member, with a central core or cavity, and a core element located within the central core or cavity. The chewing gum also comprises a dietary supplement, which may be incorporated in the central core, the cavity, or both. The core element can be of a range of consistencies, from fluid to gel-like. Optionally, the gum member may comprise crystals. Additionally, the crystals may comprise a dietary supplement. The chewing gum may be encapsulated with a coating. Multiple dietary supplements, of different or of the same varieties, may be incorporated into the chewing gum. | 2011-06-09 |
20110135709 | ADHESIVE SKIN PATCH - The present invention provides an adhesive skin patch that permits excellent and prolonged percutaneous absorption of tulobuterol and that can be stably applied to the skin for a long period of time with less skin irritation. The adhesive skin patch comprises a base material and a medicated layer provided on one surface of the base material. The medicated layer contains 1 to 30% by weight of a resolvent, 40 to 98% by weight of a pressure-sensitive adhesive, and tulobuterol. The resolvent contains an aliphatic alcohol having a branched-chain structure or a double bond in its C8 to C30 carbon chain. The pressure-sensitive adhesive is a copolymer obtained by copolymerizing monomers containing 70% by weight or more of an alkyl(meth)acrylate whose alkyl group has 6 to 20 carbon atoms. | 2011-06-09 |
20110135710 | Methods and Compositions for the Inhibition of Gene Expression - The present invention relates to methods and compositions for the inhibition of gene expression. In particular, the present invention provides oligonucleotide-based therapeutics for the inhibition of oncogenes involved in cancers. | 2011-06-09 |
20110135711 | Methods and Compositions for Delivery of Catecholic Butanes for Treatment of Tumors - The present invention provides kits, methods and compositions for the treatment of diseases such as cancers. The compositions herein contain a substantially pure preparation of at least one catecholic butane, including, for example, NDGA compounds in a pharmaceutically acceptable carrier or excipient. The catecholic butane such as NDGA or its derivatives are administered to one or more subjects in need of treatment by a route other than direct injection into the affected tissues or topical application on affected tissues. | 2011-06-09 |
20110135712 | Biologically Active Taxane Analogs And Methods Of Treatment By Oral Administration - The present invention relates to a novel chemical compound of formula S-(1): | 2011-06-09 |
20110135713 | Antimicrobial and Antiviral Compounds and Methods for Their Use - The present invention provides protonated compounds having antiviral and antimicrobial activity. The invention also provides antimicrobial compositions comprising protonated compounds of the invention. The protonated compounds of the invention provide efficacious antimicrobial activity against resistant strains of bacteria and opportunistic fungi. The invention also provides antiviral compositions comprising compounds of the invention. Viruses that may be treated by compositions of the invention include, but are not limited to, HIV, HSV, CMV, HBV, HCV and influenza virus. | 2011-06-09 |
20110135714 | COMPOSITIONS FOR EXTERNAL APPLICATION, CONTAINING ADENOSYL COBALAMIN FOR IMPROVEMENT OF SKIN DISEASES - The present invention relates to a composition for external application for improving a skin disease (e.g. psoriasis). The composition contains adenosyl cobalamin (coenzyme B12), optionally in admixture with other cobalamins. The composition can be present in the form of liposomal preparations, which are made of a phospholipid and cholesterol. | 2011-06-09 |
20110135715 | DEFENSIN-ANTIGEN FUSION PROTEINS - The present invention relates to a vaccine for increasing the immunogenicity of a tumor antigen thus allowing treatment of cancer, as well as a vaccine that increases the immunogenicity of a viral antigen, thus allowing treatment of viral infection, including immunodeficiency virus (HIV) infection. In particular, the present invention provides a fusion protein comprising a defensin fused to either a tumor antigen or viral antigen which is administered as either a protein or nucleic acid vaccine to elicit an immune response effective in treating cancer or effective in treating or preventing viral infection. | 2011-06-09 |
20110135716 | DELIVERY OF H2 ANTAGONISTS - The present invention provides improved systems and methods for the local delivery of H2 antagonists. The inventive methods include topical administration of an effective amount of a H2 antagonist encapsulated in liposomes. In certain embodiments, the H2 antagonist, for example, Cimetidine, is encapsulated into paucilamellar liposomes, such as NOVASOME® microvesicles. Also provided are pharmaceutical compositions comprising liposome-encapsulated H2 antagonists. The methods and compositions of the present invention may be used to treat any disease state or condition where local administration of H2 antagonists is beneficial. | 2011-06-09 |
20110135717 | Composition for Prevention or Treatment of Hyperlipidemia, Fatty Liver or Obesity - Disclosed is a composition for prophylaxis or treatment of hyperlipidemia, fatty liver, cardiovascular disease or obesity including a compound represented by General Formula I as an effective ingredient: | 2011-06-09 |
20110135718 | VIRAL PARTICLE-LIKE STRUCTURE IN PHYSIOLOGICAL CONDITIONS, AND METHOD OF FORMING IT - There is provided a novel method of forming uniform viral particles under physiological conditions. The method of forming uniform-sized viral particle aggregates composed of viral protein is characterized by incubating a viral protein such as SV40 virus VP1 at pH 5.0 to 7.0, room temperature, in the presence of 130 mM to 170 mM sodium chloride and 1.5 mM to 2.5 mM divalent cation, and in the presence of a particle formation acceleration factor such as SV40 VP2. For encapsulation of a substance to be encapsulated in the viral particles, the substance to be encapsulated is included during the incubation. | 2011-06-09 |
20110135719 | PHARMACEUTICAL COMPOSITION BASED ON MICRONIZED PROGESTERONE, PREPARATION METHOD AND USES THEREOF - The present invention relates to a pharmaceutical composition comprising micronized progesterone, soya bean lecithin, and at least one oil selected from the group consisting of sunflower oil, olive oil, sesame see oil, colza oil, almond oil, to the method for the preparation thereof and to the uses thereof for treating a physiological condition linked to insufficiency of progesterone secretion. | 2011-06-09 |
20110135720 | Polymer coatings containing phytochemical agents and methods for making and using same - This invention relates to compositions comprising a polymer base incorporating antifouling compositions suitable for use in aquaculture, marine and architectural systems as paints, structures or coatings. In particular, the present invention relates to a polymer based coating incorporating a biocidal antifouling composition suitable for use with aquaculture equipment. The present invention provides polyethylene compositions and latex compounds which may comprise at least one environmentally benign phytochemicals suitable for use in preventing the colonization of a treated surface by a variety of biological species. The compositions of the invention may further comprise control release agents such as, for example, micro-encapsulation of the phytochemicals to maintain sustained and prolonged release of the biocidal agents at the treated surface. | 2011-06-09 |
20110135721 | PREPARATIONS WITH ROSEHIP EXTRACTS, AND METHOD OF PRODUCING ROSEHIP EXTRACTS - Composition comprising an anti-inflammatory plant extract from rosehips together with a cartilage-protective substance, and a method of producing the rosehip extract. | 2011-06-09 |
20110135722 | PHARMACEUTICAL FORMULATION COMPRISING A PROTON PUMP INHIBITOR AND ANTACIDS - The present invention deals with a multiparticulate tablet, which disintegrates in the mouth containing: i) a proton pomp inhibiting agent, in particular of the benzimidazole type, in the form of enteric coated microgranules, which enteric coated granules are overcoated with at least one barrier coating, such as for instance a methacrylic copolymer-based protective film; ii) at least one antacid in the form of granules, for instance based on CaCO | 2011-06-09 |
20110135723 | PHARMACEUTICAL COMPOSITIONS CONTAINING PREGABALIN - The present invention provides pharmaceutical composition comprising pregabalin that is useful for once daily oral dosing. The present invention further relates to pharmaceutical composition comprising pregabalin that is useful for once daily oral dosing comprising pregabalin and on or more water insoluble components. The present invention preferably relates to a gastro-retentive tablet comprising pregabalin and one or more water insoluble component wherein water insoluble component preferably comprises of combination of ethylcellulose and hydrogenated castor oil. | 2011-06-09 |
20110135724 | Ondansetron Orally Disintegrating Tablet Compositions for Prevention of Nausea and Vomiting - This invention is related to a pharmaceutical composition in the patient-friendly orally disintegrating tablet form comprising a weakly basic, selective serotonin 5-HT | 2011-06-09 |
20110135725 | Lipid Construct for Delivery of Insulin to a Mammal - The instant invention is drawn to a hepatocyte targeted composition comprising insulin associated with a lipid construct comprising an amphipathic lipid and an extended amphipathic lipid that targets the construct to a receptor displayed by an hepatocyte. The composition can comprise a mixture of free insulin and insulin associated with the complex. The composition can be modified to protect insulin and the complex from degradation. The invention also includes methods for the manufacture of the composition and loading insulin into the composition and recycling various components of the composition. Methods of treating individuals inflicted with diabetes. | 2011-06-09 |
20110135726 | HYDROGEL COMPOSITES AND WOUND DRESSINGS - The present invention provides an absorbent hydrogel composite for use in the manufacture of an article for application to a fluid-emitting surface, e.g. a wound, the composite having a laminar structure comprising first and second layers, the first layer being a surface contacting layer comprising a porous net structure having a surface contacting face and an outwardly directed face, the second layer comprising a low-crosslinked absorbent hydrogel disposed over the outwardly directed face of the first layer and arranged so that in use it is in fluid flow communication with the surface through apertures of the net structure. | 2011-06-09 |
20110135727 | Hepatocyte Delivery Vehicle for Delivery of a Combination of Recombinant Human Regular Insulin and Recombinant Human Insulin Isophane to a Mammal - The instant invention is drawn to a hepatocyte targeted composition comprising a mixture of free recombinant human insulin isophane and free Recombinant human regular insulin insulin and a mixture of recombinant human insulin isophane and Recombinant human regular insulin insulin associated with a water insoluble target molecule complex, wherein the complex comprises multiple linked individual units and a supra-molecular lipid construct matrix. Recombinant human insulin isophane and Recombinant human regular insulin insulin are present within the complex in at least one form wherein the recombinant human insulin isophane and Recombinant human regular insulin insulin have regions of positive charge which interacts with a negative charge on the complex. The invention also includes methods for the manufacture of the composition and methods of managing blood glucose levels in individuals with Type I and Type II diabetes. | 2011-06-09 |
20110135728 | GASTRIC RETENTIVE PHARMACEUTICAL COMPOSITIONS FOR EXTENDED RELEASE OF POLYPEPTIDES - Gastric retentive dosage forms for controlled release of polypeptides are described. Methods of treatment using the dosage forms and methods of making the dosage forms are also described. | 2011-06-09 |
20110135729 | Methods for Controlling Heat Generation of Magnetic Nanoparticles and Heat Generating Nanomaterials - The present invention relates to a method for controlling heat generation of a magnetic nanomaterial, comprising the steps of: (a) mixing (i) a nanomaterial precursor comprising a metal precursor material and a predetermined amount of a zinc precursor with (ii) a reaction solvent; and (b) preparing a zinc-containing magnetic nanomaterial from the mixture of step (a) comprising a zinc doped metal oxide nanomaterial matrix; and wherein a specific loss power of the zinc-containing magnetic nanomaterial is varied depending an amount of zinc to be doped, whereby the heat generation of the magnetic nanomaterial is controlled. In addition, the present invention relates to a heat-generating nanoparticle and a composition for hyperthermia. The present invention suggests a novel approach to improve a heat generation of a magnetic nanomaterial. According to the present invention, the specific loss power can be controlled by changing a zinc-content to be introduced into nanomaterials and therefore a composition for hyperthermia showing controlled heat generation potential can be successfully provided. | 2011-06-09 |
20110135730 | Oral Formulations of Glycyl-2-Methylprolyl-Glutamate - Oral formulations of G-2MePE including microemulsions, coarse emulsions, liquid crystals, tablets and encapsulated forms of G-2MePE have improved bioavailability than conventional aqueous formulations. In particular, microparticles, nanoparticles and microemulsions can exhibit great neuroprotective effects after oral administration. In a microemulsion formulation, G-2MePE can nearly completely inhibit cerebral infarction in an animal model of stroke even after the stroke had been initiated. Thus, improved oral formulations can be desirably used to treat a variety of neurodegenerative conditions with improved convenience and improved efficacy. | 2011-06-09 |
20110135732 | MULTIPLE PHASE CROSS-LINKED COMPOSITIONS AND USES THEREOF - The present invention is directed to pharmaceutical compositions, and method for preparing pharmaceutical compositions, comprising a cross-linked matrix physically entrapping at least one therapeutic agent. The matrix may comprise one or more phases in addition to an aqueous phase, such as a solid and/or oil phase. The matrix of the invention has at least one controlled release in-vivo kinetic profile, and may have additional profiles for the same agent. The matrix may also comprise more than one therapeutic agent, and each additional therapeutic agent may have one or more controlled release in-vivo kinetic profile. | 2011-06-09 |
20110135733 | ALDEHYDE CONJUGATED FLAVONOID PREPARATIONS - There is provided a method of conjugating a polymer containing a free aldehyde group with a flavonoid in the presence of an acid catalyst, such that the polymer is conjugated to the C6 or C8 position of the flavonoid A ring. The resulting conjugates may be used to form delivery vehicles to deliver high doses of flavonoids, and may also be used as delivery vehicles to deliver an additional bioactive agent. | 2011-06-09 |
20110135734 | Method For the Preparation of Nanoparticles From Nanoemulsions - The invention relates to a method for the production of nanoparticles from oil-in-water nanoemulsions, in which the nanoemulsion is prepared by phase inversion techniques. The phase inversion may be achieved by using a constant temperature, where the inversion occurs by continuous addition of water or by varying the temperature involving heating and rapid cooling. | 2011-06-09 |
20110135735 | PROCESS FOR PRODUCTION OF A COMPOSITE MATERIAL HAVING ANTIMICROBIAL ACTIVITY - The invention relates to a process for production of a composite material having antimicrobial activity, having the following steps: provision of a metal powder produced from a metal having antimicrobial activity, wherein the metal powder is formed from discrete agglomerates having a porosity of 30 to 98%, wherein the agglomerates have a spongy structure formed by solid material bridges; melting a thermoplastic and setting a predetermined viscosity; mixing the metal powder with the molten thermoplastic in a predetermined quantitative ratio; and cooling the mixture, wherein the metal powder is firmly bound to a matrix formed by the plastic. | 2011-06-09 |
20110135736 | Compositions and Methods for Producing Vascular Occlusion using a Solid-phase Platelet Binding Agent - The present invention relates generally to methods and compositions for targeting and delivering solid-phase platelet-dependent vascular occlusion agents. In particular, particles or coils or stents coated with platelet binding agents are directed to target vasculature, such as the vasculature of solid tumor masses or AV-malformations or aneurysms or endoleaks; the solid-phase agent then binds and activates platelets, which in turn bind and activate other platelets. This process results in the rapid formation of a platelet-mediated thrombus about the solid-phase agent causing vessel occlusion. | 2011-06-09 |
20110135737 | COMPOSITIONS FOR RESPIRATORY DELIVERY OF ACTIVE AGENTS AND ASSOCIATED METHODS AND SYSTEMS - Compositions, methods and systems are provided for pulmonary or nasal delivery of active agents via a metered dose inhaler. In one embodiment, the compositions include a suspension medium, active agent particles, and suspending particles, in which the active agent particles and suspending particles form a co-suspension within the suspension medium. | 2011-06-09 |
20110135738 | SINGLE DOSAGE PHARMACEUTICAL FORMULATION COMPRISING EPROSARTAN MESYLATE - A dry formulation or granulation of eprosartan mesylate is described which comprises eprosartan mesylate in particulate form with a particle size, wherein at least 65 v/v % eprosartan mesylate particles fall in a particle size range of from 2 to 27 μm. In another aspect, a dry formulation or granulation of eprosartan mesylate comprises eprosartan mesylate combined with an excipient which at least comprises a PEG having molecular weight in the range of 400 to 20000 and mannitol. Further described is a single dosage pharmaceutical formulation such as tablet obtained from such a dry formulation or granulation of eprosartan mesylate by direct compression or dry granulation. A dry formulation or granulation of eprosartan mesylate, or a process for the preparation thereof is also described, which comprising eprosartan mesylate in particulate form mixed with one or more excipients or additives in a way that a limited water activity is obtained. The dry formulation or granulation of eprosartan mesylate can be directly compressed or processed by dry granulation, while maintaining the eprosartan mesylate in only one stable form. Suitable prophylactic and/or therapeutic uses are also described. | 2011-06-09 |
20110135739 | Oral Formulations of a Hedgehog Pathway Inhibitor - Oral formulations of the drug product IPI-926 are described. Pharmaceutical formulations (e.g., solid dosage forms) that are useful for the oral administration of a compound of formula (I), or a pharmaceutically acceptable salt thereof (e.g., IPI-926), to a human or animal subject are disclosed. | 2011-06-09 |
20110135740 | TISSUE SUBSTITUTES COMPRISING STEM CELLS AND REDUCED CERIA - A biocompatible composite includes a solid biocompatible material and a plurality of living human progenitor or living stem cells attached thereto. The composition resulting in accelerated repair to damaged bones and tissues. | 2011-06-09 |
20110135741 | SUSTAINED-RELEASE COMPOSITION AND METHOD FOR PRODUCING THE SAME - Sustained-release compositions wherein a water-soluble physiologically active peptide is substantially uniformly dispersed in a microcapsule comprised of a lactic acid polymer or a salt thereof, and the physiologically active substance is contained in an amount of 15 to 35 wt/wt % to the total microcapsules and weight-average molecular weight (Mw) of the lactic acid polymer is about 11,000 to about 27,000, which is characterized by having a high content of the physiologically active substance, and suppression of the initial excessive release within one day after the administration and a stable drug sustained-release over a long period of time, and method for producing the same. | 2011-06-09 |
20110135742 | CONTROLLED RELEASE ENCAPSULATED ANTI-BACTERIAL AND ANTI-INFLAMMATORY NANOPARTICLES - This invention pertains to the formulation of nanoparticles that have intrinsic antimicrobial and anti-inflammatory activity. The nanoparticles can be impregnated with one or more therapeutic agents and thereby enhance the antimicrobial and/or anti-inflammatory activity of such agents, and also other properties that the therapeutic agents provide. | 2011-06-09 |
20110135743 | CARBOXYVINYL POLYMER-CONTAINING NANOPARTICLE SUSPENSIONS - The present invention generally relates to suspension compositions having a carboxyvinyl polymer such as a carbomer, a galactomannan such as guar, and a borate compound. A sparingly soluble particulate compound such as nepafenac is also included in the compositions. The sparingly soluble particulate compound has a small particle size to enhance bioavailability of the compound. | 2011-06-09 |
20110135744 | Nanoparticle Based Therapy for Dispersing Mucin - There are provided compositions and methods to disperse mucin and/or actin using nanoparticles wherein the average diameter of the nanoparticles is less than about 1000 nm. | 2011-06-09 |
20110135745 | DRINK FORMULA COMPRISING FRESH MARINE OMEGA-3 OIL AND ANTIOXIDANTS - The present invention relates a new drink formula comprising fresh marine omega-3 oil in an emulsion and antioxidants well known to be health promoting to humans, and process for the production of said drink and the use of said drink for production of a medicament. | 2011-06-09 |
20110135746 | Protective lip balm composition - Lip balm formulations are disclosed that comprise a combination of anti-bacterial, anti-viral, and anti-fungal substances, including: bees wax, cocoa butter, Shea butter, Jojoba oil, Naroli oil, myrrh, tea tree oil, lavender oil, Blue Moroccan chamomile, and vitamin E and, optionally, Manuca honey and aloe vera either singularly or together with the other ingredients. | 2011-06-09 |
20110135747 | HOMEOPATHIC THERAPEUTIC METHOD - Provided are methods of topical application of an aqueous homeopathic composition for treating various ailments and injuries, including deep tissue wounds and surgical wounds. The aqueous homeopathic composition is formulated in a high potency of at least 400 C, maintained in an aqueous medium and topically applied to a bodily surface for an extended period of time to render therapeutic treatment. | 2011-06-09 |
20110135748 | USE OF A TRADITIONAL CHINESE MEDICINAL COMPOSITION FOR PREPARING MEDICINE FOR PROMOTING BONE MARROW-DERIVED MESENCHYMAL STEM CELL SURVIVAL IN VIVO AND DIFFERENTIATION INTO CARDIOMYOCYTES - The present invention discloses use of a traditional Chinese medicinal composition for preparing medicine for promoting bond marrow-derived mesenchymal stem cell survival in vivo and differentiation into cardiomyocytes. The invention also relates to use of the traditional Chinese medicinal composition for preparing the medicines for treatment of cardiovascular disease in combination with autologous bone marrow-derived mesenchymal stem cells. | 2011-06-09 |
20110135749 | LOW SHRINKAGE MULTIFUNCTIONAL SSQ RESINS - The present invention relates to low shrinkage multi functionalized silsesquioxane (SSQ) derivatives, to nanocomposite materials comprising these SSQ's and to the use of the nanocomposite material as a polymerizable resin in biologically compatible materials. | 2011-06-09 |
20110135750 | ANTI-ALLERGEN COMBINATIONS OF CALCIUM AND LANTHANUM - The present invention relates to certain combinations of alkaline earth metal salts and rare earth metal salts which provide an improved denaturing effect on allergens. More particularly, the present invention relates to compositions comprising a combination of calcium salts and lanthanum salts in respective proportions to produce a synergistic denaturing effect on allergens. Compositions comprising these combinations are particularly effective for use in an ex vivo method for denaturing allergens associated with house dust mites and other common allergens such as cat dander, molds, cockroach, pollen and the like. | 2011-06-09 |
20110135751 | PARENTERAL ADMINISTRATION OF PYROPHOSPHATE FOR PREVENTION OR TREATMENT OF PHOSPHATE OR PYROPHOSPHATE DEPLETION - A pharmaceutical composition for therapeutic administration of pyrophosphate for phosphate repletion may be in either liquid or solid form and may be usable as or usable for preparing a hemodialysis or peritoneal dialysis solution containing a pyrophosphate compound present in an amount that provides a concentration in the dialysis solution equivalent to an inorganic phosphorus concentration of at least 0.5 mg per deciliter. | 2011-06-09 |
20110135752 | Methods For Preserving Ophthalmic Solutions and Preserved Ophthalmic Solutions - A preservative system for aqueous ophthalmic solutions is provided, where the preservative system comprises a hydrogen peroxide source, at least one hydrogen peroxide stabilizer and an alkali earth metal salt. | 2011-06-09 |
20110135753 | Nutritional Supplement For Patients With Chronic Heart Failure - A nutritional supplement comprising the following approximate amounts: | 2011-06-09 |
20110135754 | CONTROL OF DISEASES IN CROPS - A composition and a method for controlling a fungal disease, such as rust, in a crop, such as a grain crop, where said composition contains a vanadium containing compound that can be applied to the seed, or to the crop, or to the ground before, during or after seeding. | 2011-06-09 |
20110135755 | Combination therapies for treating neoplastic disease - A method for treating neoplastic disease in a patient is described, which comprises administering to the patient: an antineoplastic platinum (II) complex; a physiologically acceptable source of assimilable copper; a physiologically acceptable source of assimilable manganese; a source of salicylic acid or a physiologically acceptable derivative thereof; and vitamin C. | 2011-06-09 |
20110135756 | COMPOSITIONS AND METHODS FOR PROTECTING SENSORY HAIR CELLS - The invention provides compounds, compositions and methods that can be used for the attenuation of damage to sensory hair cells and symptoms thereof. More particularly, the invention identifies drugs that can be used to protect sensory hair cells from ototoxic medications, noise-induced damage and age-related loss. | 2011-06-09 |
20110135757 | MICROAEROSOL-BASED DECONTAMINATION METHOD - A method for disinfection of a contaminated enclosed facility with microaerosol containing free radicals produced from an electrochemically-activated solution. In one embodiment of the invention the aerosol is produced from the EAS and air mixture at the air:EAS ratio (1-10):1 (by mass) with the droplets of ≦10 μm. This method is preferably performed by the atomization of the mixture with a vortex ejector nozzle with subsequent separation of coarsely dispersed particles. | 2011-06-09 |
20110135758 | Laxative and process for making same - A laxative is provided containing a mixture of prune juice, magnesium, magnesium hydroxide and purified water. | 2011-06-09 |
20110135759 | STEM CELL/ENDOTHELIAL PROGENITOR CELL MOBILIZATION BY NUTRACEUTICAL FORMULATIONS - Compositions of matter, uses, and formulations of food supplements/nutrients capable of eliciting mobilization of various stem/progenitor cells, including hematopoietic stem cells and endothelial progenitor cells are disclosed. In one embodiment a formulation contains a mixture of ellagic acid, vitamin D3, beta 1,3 glucan and a ferment of the bacterium, | 2011-06-09 |
20110135760 | Use of Extracts or Materials Extracted From Piper Cubeba L. as an Effective Component in a Drug for the Treatment of Cancer Diseases - The present invention relates to a method for the preparation of a dry extract from the fruit of | 2011-06-09 |
20110135761 | ANTIMICROBIAL SUTURE FOR MEDICAL USE WITH GRAPEFRUIT EXTRACT, AND MANUFACTURING METHOD THEREOF - There is provided an antimicrobial suture for medical use characterized in that the suture contains the grapefruit extract, and a manufacturing method thereof. The antimicrobial suture for medical use of the present invention may prevent from the pathogen infection being occurred by which the suture contains the grapefruit extract having the antimicrobial effect and provide the antimicrobial effect. | 2011-06-09 |
20110135762 | COMPOSITION COMPRISING 1,3/1 6 BETA GLUCAN FOR REDUCING WEIGHT - Beta-1,3/1,6-glucan for use as a slimming aid or in weight loss or for the treatment of obesity. | 2011-06-09 |
20110135763 | Antiseptic formulation especially for prevention of complications associated with skin burns - A composition of substances generally comprises effective amounts of a mixture of a DMSO solution in a concentration ranging between 50%-100%, Oregano oil, Lavender oil, and Bay Leaf oil. Preferably, the effective amounts constitute −50% for DMSO, −20% for Oregano oil, −10% for Lavender oil, and −20% for Bay Leaf oil of the total weight of composition. The preferable concentration of DMSO solution is 100%. The DMSO solution constricts small capillaries and the dilating of medium size blood vessels. The composition is preferably usable for prevention of complications associated with second-degree thermal or chemical skin bums, for stopping the bleeding, for healing insect bites or Jelly fish stings, and for healing skin cuts and abrasions. A method for preparation of the composition comprises—mixing the effective amounts of Oregano oil, Lavender oil, and Bay Leaf oil, obtaining a mixture and—adding the effective amount of DMSO solution into the mixture. | 2011-06-09 |
20110135764 | PEST CONTROL USING NATURAL PEST CONTROL AGENT BLENDS - Embodiments of the invention relate to a composition for controlling a target pest, wherein the composition includes at least two active ingredients selected from the group consisting of thymyl acetate, linalyl acetate, amyl butyrate, anise star oil, black seed oil, p-cymene, geraniol, isopropyl myristate, d-limonene, linalool, lilac flower oil, methyl salicylate, alpha-pinene, piperonal, piperonyl alcohol, tetrahydrolinalool, thyme oil white, thyme oil red, thymol, vanillin, and winter-green oil, wherein the composition causes synergistic control of the target pest. | 2011-06-09 |
20110135765 | SYNERGISTIC ANTIOXIDANT COMBINATIONS OF HERB EXTRACTS AND METHODS RELATING THERETO - The present invention comprises mixtures of herb extracts which exert synergistic antioxidant effect and comprise the herb licorice and at least one other herb selected from the group consisting of ginger, kudzu, sophora, and thyme. Skin care preparations incorporating such herb extract mixtures, and their methods of preparation and use, are also claimed. | 2011-06-09 |
20110135766 | PROCESS FOR EXTRACTION OF GLUCOSINOLATES FROM BROCCOLI SEEDS - A new process for extracting and purifying glucosinolates from plant material, preferably broccoli sprouts or seeds is described. An alcoholic extract is adsorbed onto a basic resin and eluted with ammonia. Optionally, the alcoholic extract is passed through an ion-exchange column containing acidic resin prior to the adsorption/elution step. | 2011-06-09 |
20110135767 | SYNERGISTIC ANTIOXIDANT COMBINATIONS OF HERB EXTRACTS AND METHODS RELATING THERETO - The present invention comprises mixtures of herb extracts which exert synergistic antioxidant effect and comprise the herb licorice and at least one other herb selected from the group consisting of ginger, kudzu, sophora, and thyme. Skin care preparations incorporating such herb extract mixtures, and their methods of preparation and use, are also claimed. | 2011-06-09 |
20110135768 | DIHYDRO-ISOALPHA ACID AND ACACIA NILOTICA EXTRACT BASED COMPOSITIONS AND METHODS FOR WEIGHT MANAGEMENT - Compositions and methods to promote or maintain weight loss utilizing dihydro-isoalpha acid compounds are disclosed. | 2011-06-09 |
20110135769 | COMPOSITIONS FOR THE TREATMENT OF DISORDERS OF THE UPPER RESPIRATORY TRACT AND INFLUENZA SYNDROMES - The present invention relates to compositions based on benzophenanthridine alkaloids, extract of | 2011-06-09 |
20110135770 | APPLES WITH HIGH POLYPHENOLIC CONTENT - The invention relates to apples comprising high concentrations of polyphenols, to processes for obtaining said apples and to uses of apples as a method of treatment or prophylaxis of cardiovascular disease, colon cancer and digestive health. | 2011-06-09 |
20110135771 | Novel Ayurvedic Formulation Advocated for the Prevention and Management of Coronary Heart Disease - A novel herbal formulation for the prevention and management of various CHD risk factors including vascular inflammatory process responsible for cardiovascular events comprising a hydro-alcoholic extraction of | 2011-06-09 |
20110135772 | SKIN CARE AGENT AND COMPOSITIONS THEREOF - A skin care agent and cosmetic and/or dermopharmaceutical compositions involving selectively polygallate molecule either singly or as a synergistic mixture of a polygallate molecule and a gallic acid ester in an effective amount along with an acceptable vehicle with or without other skin benefit agents. Preferably, the active mixture or ingredients is selectively obtained by appropriate combination of suitable sources including plants rich in individual ingredients or a single source such as the skin and/or kernel of | 2011-06-09 |
20110135773 | COMPOSITION FOR EXTERNAL SKIN APPLICATION CONTAINING PINE KNOT EXTRACT AND METHOD FOR PREPARATION OF THE SAME - Disclosed is a composition for external skin application for preventing skin aging comprising pine knot extract as an effective ingredient. The composition prevents and improves wrinkles through of skin cell proliferation and collagen biosynthesis, and may be widely applied in the field of skin beauty care and cosmetics. | 2011-06-09 |
20110135774 | Process for Preparing a Plant Extract of Passiflora Alata and Use of Said Extract in Cosmetic and Pharmaceutical Compositions - The present invention relates to the use of plant extracts of | 2011-06-09 |
20110135775 | BURNER FOR PRODUCING INORGANIC SPHERICAL PARTICLES - A burner for production of inorganic spheroidized particles according to the present invention includes a first raw material supply path ( | 2011-06-09 |
20110135776 | ANNEXED PINNING SYSTEM - A dough moulder | 2011-06-09 |
20110135777 | METHOD AND DEVICE FOR CREATIVE ART USING NYLON OR PLASTIC WASTE - Apparatus for forming a plastic material, the apparatus comprising: a brush head comprising a first set of heat conductive bristles interleaved with a second set of bristles; a handle that holds the brush head so that the brush head may be manually manipulated; and a heating element that heats the first set of bristles to a temperature sufficient to heat a plastic material by contact with the brush head to a temperature at which the plastic material is formable responsive to manual manipulation of the brush head. | 2011-06-09 |
20110135778 | LIQUID OR HYDRAULIC BLOW MOLDING - An apparatus and method for simultaneously forming and filling a plastic container is provided. A mold cavity defines an internal surface and is adapted to accept a preform. A pressure source is a servo motor system that includes an inlet. The servo motor system is operable to draw liquid through the inlet and urged it into the preform. A blow nozzle may be adapted to receive the liquid from the pressure source and transfer the liquid at high pressure into the preform thereby urging the preform to expand toward the internal surface of the mold cavity and create a resultant container. The liquid remains within the container as an end product. | 2011-06-09 |
20110135779 | Mold-Tool System having Manifold Body Defining Uninterrupted Melt Channels - A mold-tool system comprising: a manifold assembly, including: a manifold body defining: an inlet assembly; outlets being set apart from the inlet assembly; and uninterrupted melt channels extending between the inlet assembly and the outlets. | 2011-06-09 |
20110135780 | MOLD ASSEMBLY - A mold assembly includes a mold moving half, at least one heat sink positioned on the mold moving half, and a plurality of heat pipes positioned on the mold fixed half and on the at least one heat sink. The at least one heat sink includes a plurality of parallel fins. The plurality of parallel fins is secured to the heat pipes with the heat pipes passing therethrough. The heat pipes are capable of moving together with the mold moving half. | 2011-06-09 |
20110135781 | Mold-Tool System having Melt-Splitting Device Including Uninterrupted Melt Channels Extending From Inlet and Outlets - A mold-tool system ( | 2011-06-09 |
20110135782 | NUTRITIOUS FLOATING FISH FOOD - A floating fish food composition is described that comprises kibble and freeze-dried fruits and vegetables. | 2011-06-09 |
20110135783 | FRUIT AND VEGETABLES POWDERS WITH ORGANIC SUGAR ALCOHOLS - Snacks comprising an organic sugar alcohol and methods for administering servings of fruits and vegetables are provided. In a general embodiment, the present disclosure provides a snack comprising an elongated container containing a composition including an organic sugar alcohol, and a powder such as, for example, a fruit powder, a vegetable powder, an energy powder or combinations thereof. | 2011-06-09 |
20110135784 | BARLEY WITH LOW LEVELS OF HORDEINS - The present invention relates to methods of producing a food or malt-base beverage suitable for consumption by a subject with Coeliac's disease. In particular, the present invention relates to methods of producing a food or malt-based beverage with low levels of hordeins. Also provided are barley plants which produce grain that can be used in the methods of the invention. | 2011-06-09 |
20110135785 | METHODS FOR IMPROVING HEPATIC AND IMMUNE FUNCTION IN AN ANIMAL - The invention encompasses compositions and methods for improving animal health and in certain embodiments to compositions and methods for improving hepatic and immune function in aged felines. | 2011-06-09 |
20110135786 | COCOA-BASED EXERCISE RECOVERY BEVERAGES - The invention provides, in one aspect, a method of producing a ready-to-drink cocoa beverage containing high levels of beneficial cocoa flavanols or cocoa polyphenols and with a particular ratio of carbohydrates to protein. The beverages can advantageously be used in an exercise recovery regimen. Cocoa solids levels in the beverages can be selected from about 3.5% to about 10% by weight cocoa powder or the equivalent in cocoa product. | 2011-06-09 |
20110135787 | DEODORIZING COMPOSITION USING PEROXIDASE UNDER NEUTRALITY - Provided are a deodorizing composition which contains a highly safe natural plant extract that can be used in foods without anxiety as an active ingredient, and has a high deodorization effect even under a neutral condition, and a food and drink article containing the deodorizing composition. The deodorizing composition is characterized by containing a plant belonging to the genus | 2011-06-09 |
20110135788 | POLYSILOXANE (SILICONE) TREATMENT COMPOSITION FOR SUPPRESSION OF MOLD AND SPOILAGE ON ANIMAL FEED AND FORAGE, AND METHODS OF USING SAME - Polydimethylsiloxane and/or siloxane (silicone)-derived chemical compounds are used to coating harvested forages to protect against rain and/or other weather damage and to suppress mold and spoilage in harvested forages. The PDMS compound and derivatives thereof are also found to suppress the damage resulting from oxidation within the feedstuff mass. When applied, PDMS coats the feedstuff and is included in the moisture portion of the feed or forage mass. This helps preserve the feed quality and slows the damaging effects of spoilage organisms and oxidation. | 2011-06-09 |
20110135789 | COMPOSITION FOR THE RELEASE AND PROTECTION OF INSTANT ACTIVE DRY YEASTS - The present invention provides a composition for preserving the stability, the fermentative activity and for favouring the release of instant active dry yeasts. A composition of the invention can be in liquid, pasta-like or powdered form. The invention concerns also the method for preparing said composition and its different applications. | 2011-06-09 |
20110135790 | Liquid Bread Improver, The Use And The Process For Producing Thereof - The present invention relates to a water-free low viscous liquid bread improver, which comprises a liquid emulsifier based on esters of hydroxy polycarboxylic acid derivatives, a glyceride based stabilizer and additive(s) and less than about 20% oil, to the use thereof, and to a process for producing a liquid bread improver. The liquid bread improver according to the present invention may be used in, for example, a variety of products in the bakery industry or in extruded snacks. | 2011-06-09 |
20110135791 | CONCENTRATE COMPOSITION FOR PROVIDING EDIBLE CALCIUM-FORTIFIED PRODUCTS USING STABILIZED BUFFERING PROTEIN COMPONENT - A calcium-fortified concentrate having calcium citrate malate in an amount providing a level of solubilized calcium of at least about 0.2% by weight of the concentrate, and a level of total acids sufficient to impart a pH of about 4.2 or less to the concentrate; and a stabilized buffering protein component containing protein in an amount of at least about 0.75% by weight of the concentrate; pectin in an amount of at least about 0.01% by weight of the concentrate; and propylene glycol alginate in an amount of at least about 0.03% by weight of the concentrate. | 2011-06-09 |
20110135792 | SANDWICH AND METHOD FOR FORMING - A sandwich includes a partially baked sandwich insert and a chemically-leavened batter layer that envelops at least a portion of the partially baked sandwich insert. The partially baked sandwich insert includes a filling that is completely enveloped by a yeast-leavened dough. | 2011-06-09 |
20110135793 | PACKAGE FOR READY-PREPARED FOODS - The invention relates to a package for ready-prepared foods, which comprises a dish ( | 2011-06-09 |
20110135794 | PROCESS FOR PRODUCING PRECISELY SHAPED GRAIN BASED PRODUCTS - A cooking system includes a main wheel having a first surface and a secondary wheel having a second surface. The second surface of the secondary wheel mates with the first surface of the main wheel at a nip to form and set a grain based material disposed between the first and second surfaces. The grain based material may be dried, toasted, baked, puffed, or blistered between first and second surfaces. The method begins by disposing a cooked or uncooked grain based material over the first surface. The second surface, which corresponds to the first surface is applied to the grain based material at the nip to form and set the grain based material between the first and second surfaces. At least one of the first and second surfaces is heated to heat the grain based material disposed between the first and second surfaces to produce a ready-to-eat grain based product. | 2011-06-09 |
20110135795 | Tamale maker - A device and method for making Tamales having: a lower surface, an upper surface, connecting means for attaching said upper surface to the lower surface, the lower surface has means for receiving a tamale wrapper, the upper surface has a cut out portion in the middle of the upper surface for applying a masa spread to the tamale wrapper on the lower surface, wherein a user desires to make tamales, the tamale wrapper is positioned such that the front of the tamale wrapped is positioned over the cut out hole in the upper surface, then the upper surface is positioned on the tamale wrapper to prevent the wrapper from moving, then said masa spread is applied to the tamale wrapper through the cut out portion, then a leveling device is used to compact the masa, then the leveling device is used to scrap away any excess masa spread, and wherein the masa spread has been applied to the tamale wrapper, then a tamale filling is placed on a portion of the masa spread, then the tamale wrapper with the masa spread is folded over the tamale filing to trap the filling between the masa spread so that the tamale is now ready for cooking. | 2011-06-09 |